期刊文献+

磷霉素与氨基糖苷类药物联合应用的研究进展 被引量:9

The progressive study of the combination of fosfomycin and aminoglycosides
下载PDF
导出
摘要 磷霉素不同于任何其他抗菌药物,具有独特化学结构与抗菌机制,与一些抗菌药物联用呈现协同作用;氨基糖苷类药物抗菌谱广、杀菌活性强,但耳、肾毒性限制了其临床应用。本文拟通过药效学特性、药物安全性以及细菌生物被膜3部分内容,综述磷霉素与氨基糖苷类药物联合应用的研究进展,以期为临床联合用药提供参考,促进临床安全合理用药。 Fosfomycin possess distinct chemical constitution and antibiosis mechanism other than any other antibacterials, and has sysnergistic effect with other antibacterials.Aminoglycosides has wide antibacterial spectrum and powerful bactericidal activity,but ototoxicity and renal toxicity limit its clinical appli cation.This article aims to offer information for clinical by reviewed the progressive study of the combination of fosfomycin and aminoglycosides -including three sectors:pharmacodynamics characteristics,drug safety,bacterial biofilm-to ensure the rational use of drug in clinical.
出处 《中国药物警戒》 2007年第3期171-175,共5页 Chinese Journal of Pharmacovigilance
关键词 磷霉素 氨基糖苷类药物 细菌生物被膜 fosfomycin aminoglycosides bacterial biofilm(BBF)
  • 相关文献

参考文献20

  • 1[1]Patel S S,Balfoud J A,Bryson H M.Fosfomycin tromethamine.Are view of its antibacterial activity,Pharmacokinetic properties and therapeutic efficacy as a single dose oral treatment for acute uncomplicated lower urinary tract infections[J].Drugs,1997,53 (4):637.
  • 2[3]Wanke C,Amrhein N.Evidence that the reaction of the UDPN-acetylglucosamine 1-carboxyvinyltransferase proceeds throght the O-phosphothioketal of pyruvicacid bound to Cys 115 of enzyme[J].Eur J Biochem,1993;218:861.
  • 3[4]Marquardt J L,Brown E D,Lane W S,et al.Kinetics stoichiometry,and identification of reactive thiolate in the inactivation of UDP-GlcNAc enolpyruvol transferase by the antibiotic fosfomycin[J].Biochemistry,1994,33:10646.
  • 4[5]Kim D H,Lees W J,Kempsell K E,et al.Characterization of a Cys 115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl trans-ferase (MurA) that confers resistance to inactivation by antibiotic fosfomycin.Biochemistry[J],1996;35:4928.
  • 5林泉.二段疗法 [J].化学疗法の领域,1995,11(1):281-281.
  • 6佟金平,王镇山,薛欣,顾俊明.磷霉素与14种抗菌药物分别联用的体外抗菌活性研究[J].中国抗生素杂志,2005,30(4):233-237. 被引量:26
  • 7高福仁,张艳霞.磷霉素庆大霉素治疗急性婴幼儿菌痢疗效观察[J].实用全科医学,2005,3(1):45-45. 被引量:5
  • 8徐靖,徐兵,付惠玲,李丽萍.磷霉素与丁胺卡那霉素联合治疗细菌性痢疾[J].新乡医学院学报,1997,14(3):282-283. 被引量:8
  • 9[10]Morin J P,Bendirdjian J P,Pillastre A,et al.Interference of fosfomycin with lysosomal membrane integrity of rat kidney cells[J].Drugs Exptl Clin Res,1978;4:63.
  • 10[11]Yanagida C,Ito K,Komiya I,Horie T.Protective effect of fosfomycin on gentamicin-induced lipid peroxidation of rat renal tissue[J].Chem Biol Interact,2004,148(3):139-147.

二级参考文献28

  • 1虞爱华,方鹤松.小儿感染性腹泻的抗生素治疗[J].中国实用儿科杂志,1993,8(4):201-203. 被引量:57
  • 2Grif K, Manfred P D, Pfaller K, et al. In vitro activity of fosfomycin in combination with various antistaphyloccal substances [J]. J Antimicrob Chemother , 2001,48: 209.
  • 3Utsui Y, Ohya S, Magaribuchi T, et al. Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus [J]. Antimicrob Agents Chemother, 1986,30(6):917.
  • 4NCCLS. Performance Standards for antimicrobial susceptibility testing [S]. 2002, vol. 22 No. 1 M100-S12 M2-A7andM7-A5.
  • 5倪语星 洪秀华.联合药物敏感试验和体外杀菌试验[A]..细菌耐药性监测与抗感染治疗[M].北京:人民军医出版社,2002-4.83.
  • 6Nabin K, Shrestha J, Tomford W. Fosfomycin: A review [J]. Infect Dis Clin Prac ,2001,10(5 ) :255.
  • 7Del V O, Trincado P, Martin M T, et al. The prevalence of methicillin-resistant Staphylococcus aureus phagotype 95in the Hospitals vall d' Hebron of Barcelona [J]. Enferm Infecc Microbiol Clin,1999,17(10):498.
  • 8Yoshida R, Kuwahara-Arai K, Baba T, et al. Physiological and molecular analysis of a mecA-negative Staphylococcus aureus clinical strain that expresses heterogeneous methicillin resistance [J]. J Antimicrob Chemoth, 2003,51:247.
  • 9Robert D S, John S B. Evolving antimicrobial chemotherapy for Staphylococcus aureus infections [J]. Crit care Med,2001,29(Suppl 4) :N92.
  • 10Watanabe T, Kanno M, Sobu K, et al. In vitro studies on the combined effects of arbekacin and fosfomycin on methicillin-resistant Staphylococcus aureus [ J ]. J Antibiot, 1995,48 (2): 284.

共引文献50

同被引文献72

引证文献9

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部